COVID-19疫情下妇科恶性肿瘤的临床管理策略  

Clinical Management of Gynecological Cancer Patients During COVID-19 Epidemic

作　　者：范莹 吴鹏[1] 刘眈 张宏 高杰 卢吉 陈刚[1] 马丁[1] 张玮 FAN Ying;WU Peng;LIU Dan;ZHANG Hong;GAO Jie;LU Ji;CHEN Gang;MA Ding;ZHANG Wei(Department of Obstetrics and Gynecology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China)

机构地区：[1]华中科技大学同济医学院附属同济医院妇产科,武汉430030

出　　处：《肿瘤防治研究》2020年第10期771-775,共5页Cancer Research on Prevention and Treatment

摘　　要：新冠肺炎疫情期间,由于医疗资源的再分配,妇科恶性肿瘤患者的常规医疗受到极大影响。恶性肿瘤患者因为接受抗肿瘤治疗后免疫力低,合并感染后症状重,成为疫情的易感人群和预防的重点对象。随着疫情的好转,妇科恶性肿瘤患者的治疗需求尤为强烈。在复杂的新冠肺炎疫情下,接受化疗、免疫治疗及需手术治疗的妇科恶性肿瘤患者如出现发热及呼吸道症状,更需要仔细地进行鉴别诊断,评估新冠肺炎感染的风险。因此对于这一类患者,在新冠肺炎疫情期间的抗肿瘤治疗,需要进行全面的管理。本文从对手术患者及化疗、免疫治疗患者的门诊管理、院内患者及陪同人员、医护工作人员的管理及对患者的院外管理三个方面全面阐述了COVID-19疫情下,妇科恶性肿瘤的临床管理策略,力求在有效防范新冠肺炎的同时,最大程度地治疗肿瘤。During the epidemic of COVID-19,the routine clinical treatment for gynecological cancer patients has been disturbed due to the redistribution of medical resource.Due to the systemic immunosuppression caused by the malignancy and anticancer treatments,gynecological cancer patients are more susceptible to COVID-19.With the improvement of the epidemic,the treatment needs of gynecological cancer patients are extremely strong.During this special period,it should carefully identify fever and respiratory symptoms of gynecological cancer patients receiving chemotherapy,immunotherapy and operations.Therefore,it is quite necessary to carry out comprehensive clinical management.We introduce a clinical management of gynecological cancer patients in three aspects of outpatient,in-hospital and out-of-hospital management during this period,in order to maximize the treatment of tumors and effectively prevent COVID-19.

关 键 词：妇科恶性肿瘤 临床管理 新型冠状病毒肺炎 

分 类 号：R737.3[医药卫生—肿瘤]